Cargando…

Magnetic-Assisted Treatment of Liver Fibrosis

Chronic liver injury can be induced by viruses, toxins, cellular activation, and metabolic dysregulation and can lead to liver fibrosis. Hepatic fibrosis still remains a major burden on the global health systems. Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Levada, Kateryna, Omelyanchik, Alexander, Rodionova, Valeria, Weiskirchen, Ralf, Bartneck, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830324/ https://www.ncbi.nlm.nih.gov/pubmed/31635053 http://dx.doi.org/10.3390/cells8101279

Ejemplares similares

Spatial Manipulation of Particles and Cells at Micro- and Nanoscale via Magnetic Forces
por: Panina, Larissa V., et al.
Publicado: (2022)

Ultrasensitive Magnetic Field Sensors for Biomedical Applications
por: Murzin, Dmitry, et al.
Publicado: (2020)

Green Synthesis of Co-Zn Spinel Ferrite Nanoparticles: Magnetic and Intrinsic Antimicrobial Properties
por: Omelyanchik, Alexander, et al.
Publicado: (2020)

Multifunctional Fe(3)O(4)-Au Nanoparticles for the MRI Diagnosis and Potential Treatment of Liver Cancer
por: Kozenkova, Elena, et al.
Publicado: (2020)

Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts
por: Weiskirchen, Ralf, et al.
Publicado: (2018)

Effect of Piezoelectric BaTiO(3) Filler on Mechanical and Magnetoelectric Properties of Zn(0.25)Co(0.75)Fe(2)O(4)/PVDF-TrFE Composites
por: Sobolev, Kirill, et al.
Publicado: (2022)

Progressive lysosomal membrane permeabilization induced by iron oxide nanoparticles drives hepatic cell autophagy and apoptosis
por: Levada, Kateryna, et al.
Publicado: (2020)

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
por: Schon, Hans-Theo, et al.
Publicado: (2016)

Cellular Mechanisms of Liver Fibrosis
por: Acharya, Pragyan, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention
por: Tacke, Frank, et al.
Publicado: (2021)

Editorial: Inflammation and Fibrosis in the Gastrointestinal Tract and Liver: Mechanisms and Targets
por: Weiskirchen, Ralf, et al.
Publicado: (2021)

Expression of Cyclin E1 in hepatic stellate cells is critical for the induction and progression of liver fibrosis and hepatocellular carcinoma in mice
por: Otto, Julia, et al.
Publicado: (2023)

It’s all about the spaces between cells: role of extracellular matrix in liver fibrosis
por: Khurana, Amit, et al.
Publicado: (2021)

Mechanisms Underlying Cell Therapy in Liver Fibrosis: An Overview
por: Pinheiro, Daphne, et al.
Publicado: (2019)

Roles of CCR2 and CCR5 for Hepatic Macrophage Polarization in Mice With Liver Parenchymal Cell-Specific NEMO Deletion
por: Bartneck, Matthias, et al.
Publicado: (2020)

Boosting Magnetoelectric Effect in Polymer-Based Nanocomposites
por: Omelyanchik, Alexander, et al.
Publicado: (2021)

Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
por: Drescher, Hannah K., et al.
Publicado: (2019)

Endoglin in human liver disease and murine models of liver fibrosis—A protective factor against liver fibrosis
por: Alsamman, Muhammad, et al.
Publicado: (2017)

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
por: Tag, Carmen G., et al.
Publicado: (2015)

Experimental liver fibrosis research: update on animal models, legal issues and translational aspects
por: Liedtke, Christian, et al.
Publicado: (2013)

Relevance of Autophagy in Parenchymal and Non-Parenchymal Liver Cells for Health and Disease
por: Weiskirchen, Ralf, et al.
Publicado: (2019)

Special Issue on “Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis”
por: Weiskirchen, Ralf
Publicado: (2020)

Special Issue on “Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II”
por: Weiskirchen, Ralf
Publicado: (2022)

All You Can Feed: Some Comments on Production of Mouse Diets Used in Biomedical Research with Special Emphasis on Non-Alcoholic Fatty Liver Disease Research
por: Weiskirchen, Sabine, et al.
Publicado: (2020)

Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis
por: Krenkel, Oliver, et al.
Publicado: (2019)

Therapeutic Targeting of Neutrophil Granulocytes in Inflammatory Liver Disease
por: Bartneck, Matthias, et al.
Publicado: (2019)

Mast Cells in Liver Fibrogenesis
por: Weiskirchen, Ralf, et al.
Publicado: (2019)

Multiferroic Coupling of Ferromagnetic and Ferroelectric Particles through Elastic Polymers
por: Makarova, Liudmila A., et al.
Publicado: (2021)

Star-Shaped Magnetic-Plasmonic Au@Fe(3)O(4) Nano-Heterostructures for Photothermal Therapy
por: Muzzi, Beatrice, et al.
Publicado: (2022)

Development and evaluation of an open source Delphi-based software for morphometric quantification of liver fibrosis
por: Huss, Sebastian, et al.
Publicado: (2010)

Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets
por: Gressner, A M, et al.
Publicado: (2006)

Isolation and Time Lapse Microscopy of Highly Pure Hepatic Stellate Cells
por: Bartneck, Matthias, et al.
Publicado: (2015)

Magnetocrystalline and Surface Anisotropy in CoFe(2)O(4) Nanoparticles
por: Omelyanchik, Alexander, et al.
Publicado: (2020)

Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options
por: Gressner, Olav A, et al.
Publicado: (2007)

Soft Magnetic Amorphous Microwires for Stress and Temperature Sensory Applications
por: Panina, Larissa, et al.
Publicado: (2019)

α2-Adrenergic Receptor in Liver Fibrosis: Implications for the Adrenoblocker Mesedin
por: Schwinghammer, Ute A., et al.
Publicado: (2020)

Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases
por: van der Heide, Daphne, et al.
Publicado: (2019)

Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury
por: Weiskirchen, Ralf
Publicado: (2019)

Immunomodulatory Nanomedicine for the Treatment of Atherosclerosis
por: Peters, Linsey J. F., et al.
Publicado: (2021)

Deficiency in four and one half LIM domain protein 2 (FHL2) aggravates liver fibrosis in mice
por: Huss, Sebastian, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fcgqmq3aqadcajj74iqr6gi43n